Fitness Trends Robotic Rehabilitation and Assistive Technologies | Página 3

• Stroke
• Orthopedics
• Cognitive & Motor Skills
• Sports
• Others
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/robotic-rehabilitation-and-assistive-
technologies-market-924
Europe is expected to dominate the robotic rehabilitation and assistive technologies market
Regional segmentation of robotic rehabilitation and assistive technologies market by Coherent
Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa. Europe is expected to hold a dominant position in the robotic rehabilitation and assistive
technologies market throughout the forecast period due to increasing prevalence of disabilities
in the region. According to an article published by The Institute of Modern Russia, around 13
million people live with certain disabilities, constituting to around 9% of the total population in
the country. Furthermore, researchers at the University of Hertfordshire, along with European
partners have developed a robotic glove intended for stroke patients. It can be used in home
settings to support rehabilitation. North America is expected to be the second-largest market,
due to robust technological infrastructure and inclination of the population towards adoption of
new technologies.
Key players in the market are partnering with healthcare providers to increase market
penetration
Key players in robotic rehabilitation and assistive technologies market include Mazor Robotics
Ltd., Intuitive Surgical Inc., Accuray, Inc., Health Robotics S.R.L., Kinova, AlterG inc., Ekso
Bionics, and Interactive Motion Technologies, Bioxtreme Robotics Rehabilitation, Instead
Technologies. In 2016, Ekso Bionics Holdings, Inc., received U.S. Food and Drug Administration
(FDA) approval for Ekso GT robotic exoskeleton. This product is used to treat an individual
with hemiplegia which occur due to stroke.
To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/
buy-now/924